The cloud computing, through the virtualization of data, will help pharmaceutical industry optimize next-generation DNA sequencing and clinical trials data, according to GBI Research report.
The report "Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management" focuses on next-generation sequencing, bioinformatics, transfer of information across the sales force and clinical trials data management.
The report provides technological concepts in cloud computing, including cloud computing service models, deployment models and key stakeholders.
The report is reinforced using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.
GBI Research studies reveal that cloud computing has managed to change the invention, development, deployment updating and maintenance of information technology (IT) services.
